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Abstract. We have previously shown that postnatal 
expression of the viral oncoprotein SV40 T antigen in 
rod photoreceptors (transgene MOT1), at a time when 
retinal cells have withdrawn from the mitotic cycle, 
leads to photoreceptor cell death (Al-Ubaidi et al., 
1992. Proc. Natl. Acad. Sci. USA. 89:1194-1198). To 
study the effect of the specificity of the promoter, we 
replaced the mouse opsin promoter in MOT1 by a 1.3­
kb promoter fragment of the human IRBP gene which 
is expressed in both rod and cone photoreceptors dur­
ing embryonic development. The resulting construct, 
termed HIT1, was injected into mouse embryos and 
five transgenic mice lines were established. Mice het­
erozygous for HIT1 exhibited early bilateral retinal 
and brain tumors with varying degrees of incidence.
E x p r e s s io n  of viral oncogenes typically promotes 
tumorigenesis in various tissues of transgenic mice 
' (18, 29). The oncogene that was most frequently 
used to induce tumor formation is simian virus 40 (SV40) 
large tumor antigen (T antigen) (18, 29), which is essential 
for both viral replication and cell transformation (8, 37). T 
antigen has been found to interact with several cellular pro­
teins involved in tumor suppression (12, 23), DNA replica­
tion (14), and regulation of transcription (15, 38), but its pre­
cise role in oncogenesis is not well understood. Accidental 
expression of SV40 T antigen in the retina of transgenic mice 
has led to the generation of tumors originating in various 
retinal cell types (4, 17, 21, 36), except photoreceptors. 
Brain and retinoblastomalike ocular tumors originating in 
the inner nuclear layer were induced in one of fifteen trans­
genic families that harbored a hybrid gene consisting of the 
human /S-luteinizing hormone gene promoter and the T anti­
gen gene (39). Inheritable human retinoblastomas, typically 
caused by a defect in the rb  gene, arise from retinal em­
bryonic neuroepithelial cells and often express components 
of the cone, but not the rod phototransduction cascade in tis­
sue culture (5, 20).
We previously showed that T antigen expression driven by 
the mouse opsin promoter caused an early and rapidly
©  The Rockefeller University Press, 0021-9525/92/12/1681/7 $2.00
The Journal of Cell Biology, Volume 119, Number 6, December 1992 1681-1687
Histopathological examination of the brain and eyes of 
three of the families showed typical primitive neuro­
ectodermal tumors. In some of the bilateral retinal 
tumors, peculiar rosettes were observed, which were 
different from the Flexner-Wintersteiner rosettes typi­
cally associated with human retinoblastomas. The 
ocular and cerebral tumors, however, contained 
Homer-Wright rosettes, and showed varying degrees of 
immunoreactivity to antibodies against the neuronal 
specific antigens, synaptophysin and Leu7, but not to 
antibodies against photoreceptor specific proteins. 
Taken together, the results indicate that the specificity 
of the promoter used for T antigen and/or the time of 
onset of transgene expression determines the fete of 
photoreceptor cells expressing T antigen.
progressing rod photoreceptor degeneration, and at a later 
stage, the development of brain tumors (2). The rod pho­
toreceptor degeneration, as evidenced by pyknotic nuclei 
and shrinkage of the outer nuclear layer, began around post­
natal day 8 (P8), and was complete by P21. T antigen expres­
sion, under control of the opsin promoter, was shown to be­
gin between PI and P5, and reached maximum levels before 
onset of the degeneration. In the retina, rod opsin is ex­
pressed exclusively in rods, whereas interphotoreceptor 
retinoid-binding protein (IRBP)1 is known to be expressed 
in both rods and cones (31). Both proteins are expressed to 
a much lesser extent in pinealocytes in the brain (24). Ex­
pression of IRBP precedes expression of rhodopsin, and can 
be detected at embryonic day 17 (E17) (9). Expression of a 
bacterial reporter gene (chloramphenicol acetyltransferase, 
CAT) under the control of the human IRBP promoter indi­
cated an even earlier onset of expression (27). To study the 
effect of onset of expression of T antigen and the cell type 
specificity of the promoter, the human IRBP promoter frag­
ment was used to direct expression of T antigen to the retina
1. Abbreviations used in this paper: CAT, chloramphenicol aeetyltransfer- 
ase; GFAP, glial fibrillary acidic protein; IRBP, interphotoreceptor 








of transgenic mice. In this paper we show that expression of 
SV40 T antigen under the control of a 1.3-kb human IRBP 
promoter fragment causes the formation of trilateral tumors 
involving the eyes and brain. Bilateral retinal tumors appear 
to arise in the outer nuclear layer of the retina.
Methods
Production of M/rd, Cat/+Mke
Mice homozygous for the rd mutation exhibit complete degeneration of the 
photoreceptor cell layer about the third week of postnatal development (28). 
FVB/N (rd/rd) mice and transgenic mice homozygous for the IRBP/CAT 
transgene were mated, and FI mice, heterozygous for both rd and IRBP/ 
CAT, were then mated to FVB/N to produce mice that are homozygous for 
the rd mutation and heterozygous for the IRBP/CAT transgene. Mice that 
were heterozygous for both the IRBP/CAT and rd were used as controls. 
The presence of the rd allele was detected by the rd specific Ddel poly­
morphism (30). The IRBP/CAT transgene was detected as described pre­
viously (24).
RNAse Protection Assay
Fragments of antisense RNA (259 or 392 nucleotides [nt] for mouse IRBP, 
363 nt for CAT, and 300 nt for /3 actin) were synthesized in the presence 
of [of-32P]UTP using T3 or T7 RNA polymerase (Promega Corp., Madi­
son,, WI) using corresponding linearized subclones in Bluescript plasmid
(25). The synthesized probes were gel purified and were used in excess 
(200-900 pg) hybridize with 0.1 jig of poly(A) mRNA or 2 Mg total RNA. 
Hybridization was carried out at 42°C overnight in the presence of 50% 
deionized formamide, 40 mM Pipes pH 6.4, 400 mM NaOAc and 1 mM 
EDTA. After hybridization the mixture was treated with 10 units of RNAse 
A and 2,000 U of RNAse TI, and protected fragments were separated by 
polyacrylamide gel electrophoresis. Autoradiographs were quantitated 
using a Shimadzu densitometer. The sizes of protected fragments were: 245 
or 311 nt for mouse IRBP; 108 nt for mouse opsin; 309 nt for CAT; and 
250 nt for /3-actin.
Chloramphenicol Acetyltransferase Assay
CAT activity was measured in retinas or eyes (at early embryonic stages) 
as described previously (19). One unit of CAT activity was defined as the 
amount of activity capable of acetylating 1 mmol of chloramphenicol/min 
at 37°C. Protein concentrations were determined by the Bradford method 
(Bio-Rad Laboratories, Richmond, CA) (6).
Preparation of the HIT1 Construct
The 5' flanking fragment of the human IRBP gene was digested with PvuII 
and ligated to Smal digested pUC18 to produce phIRBP-1.3. phIRBP-1.3 was 
then digested with EcoRI and BamHI and the gel purified fragment of the 
human IRBP promoter was inserted into the EcoRI/BamHI sites of the 
promoterless plasmid paA366a-T (26). The resultant construct (HIT1) was 
digested with BstUI to yield a 4.5-kb fragment containing the human IRBP 
promoter sequences, the entire coding sequences for the SV40 T antigen, 
and some flanking sequences from the plasmid pBR322.
Generation of HIT1 Transgenic Mice
Transgenic mice were produced using previously established protocols 
(29), where the BstUI fragment of the HIT1 construct (at 1 mg/ml in 10 
mM Tris, 0.1 mM EDTA, pH 8.0) was injected in single cell mouse em­
bryos. Transgenic founder mice (F0) were identified by either blot hybrid­
ization or by PCR (2). For PCR analysis, DNA extracted from ear punches 
was used in an amplification reaction in the presence of human IRBP 
specific primer (5' CAGTGTCTGGCATGTAGCAGG 31) and a T antigen 
specific primer (5' CATCCTCAGTAAGCACAGCA 31) which produced 600 
bp fragment upon amplification. Founder mice were mated to C57BL/6 
mice to produce the first (FI) and subsequent generations of mice used for 
the study. Blot analysis was performed as described (33) and washings were 
performed at 55°C.
Histology
Transgenic mice with brain and retinal tumors were killed by cervical dislo­
cation and the eyes and brains removed and fixed in 4% phosphate-buffered 
formaldehyde. Tissues were embedded in paraffin and 5 fim sections of the 
eye and brain were cut, stained with hematoxylin-eosin, and examined.
Immunocytochemistry
The ocular and brain tumors were fixed in 10% buffered formalin solution. 
Four micron sections of the tumors were prepared and the sections were 
deparaffinized and hydrated in decreasing ethanol concentrations. Incuba­
tion of die sections with the primary antibody followed by the secondary 
antibody and finally the avidin-biotin complex method (kit and methods ob­
tained from Fisher Scientific Co., Pittsburgh, PA) were all performed in a 
moist chamber at 37°C. As chromogen, amino-ethyl carbazole was used. 
Sections were counterstained with Mayer’s hematoxylin for 1 min. Immuno- 
cytochemical staining to demonstrate photoreceptor specific antigens were 
performed using the following antibodies: bovine opsin (gift from Dr. Paul 
Haig rave [University of Florida, Gainesville, FLJ, R2-12N and K16-155C 
[1]), bovine phosphodiesterase (gift from Dr. Bernard Fung [UCLA School 
of Medicine, Los Angeles, CA], MOE1), and S antigen (gift from Dr. Larry 
Donoso [Wills Eye Hospital, Philadelphia, PA], MAB-A9C6 [13]). Hybri- 
domas producing antibodies against T antigen (PAB100) were obtained 
from the American Type Culture Collection (Rockville, MD) (16). Anti­
bodies against synaptophysin (Boehringer Mannheim Corp., Indianapolis, 
IN), cytokeratins (Boehringer Mannheim), and antibodies against Leitf 
(Becton Dickinson bnmunocytometry Systems, Mountain View, CA) were 
also used. Antibodies against glial fibrillary acidic protein (GFAP), neuron- 
specific enolase (NSE) and neurofilament (NF) were obtained from Dako 
Corp. (Santa Barbara, CA). For controls, eyes and brains from normal lit- 
termates were used.
Results
Onset of Gene Expression Under the Control of the 
hlRBP Promoter
The hlRBP promoter directs expression of a bacterial 
reporter gene, CAT, to the retina and to a much lesser extent 
to the brain (pinealocytes) of transgenic animals (24). To 
study ftte onset of CAT expression in the embryonic retina 
of a transgenic mouse heterozygous for the hlRBP/CAT 
transgene, we determined the amount of CAT transcripts at 
various stages of embryonic development by an RNase pro­
tection assay (RPA). Fig. 1 shows that CAT transcripts and 
hence transgene expression under the control of the IRBP 
promoter can be detected as early as E13, at least one week 
earlier than opsin expression (3).
Cell Specificity
To study the cell specificity of the IRBP promoter, we used 
a genetic approach in which mice homozygous for the 
IRBP/CAT transgene were mated with mice homozygous for 
the rd locus. Mice heterozygous for the rd allele develop nor­
mal retinas (32), while mice homozygous for the rd allele 
suffer a rod photoreceptor degeneration. CAT activity in the 
retinas of offspring homozygous for the rd allele and hetero­
zygous for IRBP/CAT were assayed at different stages of 
postnatal development. Mice that were heterozygous for 
both the rd allele and IRBP/CAT transgene served as con­
trols. As seen in Fig. 1, CAT activity in both rd/rd and rd/+ 
animals rose during the first few days of retinal development. 
A sharp increase was seen at P7, a time when the last mitotic 
figures are normally observed in the retina of the mouse (10, 
41). While CAT activity in the rd/+ animals continued to 
rise, after an initial decline, a pronounced decrease of CAT 
activity in the retina of rd/rd animals was observed. This de-









Figure 1. CAT expression during prenatal and postnatal develop­
ment of the retina. Prenatal expression of the hIRBP/CAT transgene 
was monitored by RNase protection. Postnatal expression of the 
transgene was measured by assaying CAT activity (mU/mg protein) 
(24). Retinal samples were obtained from mice at different stages 
of postnatal development. Diamonds represent the amount of CAT 
transcripts, as determined quantitatively from an autoradiogram. 
Triangles represent activity in retinas from mice that are heterozy­
gous for both the rd allele and the CAT transgene, whereas circles 
represent activity in retinas of animals homozygous for the rd allele 
and heterozygous for the CAT transgene. Error bars are calculated 










Figure 2. Transgenic constructs. Upper part: organization of the hu­
man IRBP gene. The filled boxes depict coding sequences, lines de­
pict introns and flanking regions. Open boxes represent the 5' and 
3' untranslated regions of the exons. The 1.3-kb promoter region 
of the human IRBP gene (heavy line) is flanked by two PvuH sites. 
Transgene hIRBP/CAT: The 1.3 kb hIRBP promoter fragment was 
fused to the CAT gene as described (24). The stippled box depicts 
the SV40 small t antigen intron and the SV40 early region polyade- 
nylation site. Transgene HIT1: The 1.3-kb PvuII fragment contain­
ing the human IRBP promoter sequences was fused to the 5' end 
of the SV40 T antigen gene with its own polyadenylation signals 
contained in the plasmid PaA366a-T (26). Dotted box, genomic se­
quences upstream of the aA-crystallin promoter. Tsp depicts the 
transcription start site of the human IRBP gene. Hatched box, SV40 
T antigen coding sequence. The 4.3-kb BstUI restriction fragment 
used for microinjection is shown.
cline in CAT activity continued until it reached a constant 
level of 8-10% of the activity in control retinas at postnatal 
day 21. The reduction of CAT activity is associated with rod 
photoreceptor degeneration, usually completed at about the 
end of the third week of postnatal development (28). Because 
cone photoreceptor cells have been detected in rd/rd mice as 
late as 6 mo of age (22), persisting cone photoreceptor cells 
most likely continued to express CAT activity at P20 (Fig. 
1). Because all other cell types in the retina remain intact, 
these results indicate that the hIRBP promoter directs ex­
pression of the bacterial CAT gene specifically to pho­
toreceptor cells.
The HIT1 Construct
To study the effect of onset of expression of SV40 T antigen 
in the developing photoreceptor cell layer of transgenic 
mice, the hIRBP promoter was fused to the SV40 large T an­
tigen sequences to yield construct HIT1 (Fig. 2). HIT1 con­
tains the transcription start site and upstream promoter of the 
human IRBP gene, and the complete coding sequences of the 
viral oncogene. In addition to an early onset of T antigen ex­
pression, the IRBP promoter is expected to direct expression 
of the antigen to both rods and cones. HIT1 was injected into
1-d old FVB/N mouse embryos (35) and five transgenic 
founder mice were established. Southern blot analysis of 
genomic DNA from the founder mice and their offspring 
(data not shown) from a mating to C57BL/6 showed a Men- 
delian fashion of inheritance of the transgene and indicated 
the integration of multiple copies of the transgene at single 
sites (Table I).
Expression of H ill Causes Dilateral Tumors
All of the transgenic mice families that harbored HIT1 ex­
hibited retinal and brain tumors, albeit at varying incidence 
levels (Table I). The tumors were consistently trilateral and 
appear to initiate at embryonic or early postnatal stages. 
Most ocular and brain tumors were poorly differentiated 
with a variable degree of anaplasia and bizarre pleomorphic 
nuclei. The ocular tumors led to total retinal detachment 
with the tumor cells involving mostly the outer retinal layers 
(Figs. 3 A and 4 A). The inner retina (inner plexiform and 
ganglion cell layers) appeared intact and in many sections, 
the tumor cells merged imperceptibly with the bipolar cell 
layer (Fig. 4 A). While most of the ocular tumors were 
poorly differentiated, some tumors were more differentiated 
and disclosed peculiar rosettes composed of a single layer of 
cuboidal cells that were centered around a small capillary 
lined by a single layer of flat endothelial cells (Fig. 3 B).
Table I. Characterization of Transgenic Mice Families 
Harboring the HIT1 Fusion Gene
Family (F0)
Characteristics 408 413 414 417 437
Phenotype None BT, ET BT, ET BT, ET BT, ET
Tumor incidence (%) 1 95 63 1 0 0 1 0 0
Transmittance (%) 43 38 55 50 50
Integration site(s) 1 1 1 1 1
Copies per haploid 2 8 2 3 9
Southern analysis (33) performed on tail DNA samples of the founder mice and 
their offspring from a mating to C57BL/6, was used to obtain the number of 
copies of the transgene, the number of sites of integration and rate of transmit­
tance of the transgene. A total of 145 mice from different families were in­
volved in generating these results. Tumor incidence (%) was calculated by 
dividing the number of mice that developed tumors after weaning by the total 
number of weaned mice for each transgenic family. BT, brain tumor; ET, eye 
tumor.






Figure 3. Histopathological characterization of the retinal and brain tumors. (A) Section of an enucleated right eye from a 60-d old mouse 
(FO 417) displaying a large retinal tumor (hematoxylin-eosin, 27X). The tumor originates from the outer retinal layers and extends into 
the subretinal space. (B) Retinal tumor from a mouse killed at age 45 d. (FO 417) showing a primitive neuroectodermal neoplasm containing 
neuroepithelial rosettes, most of which are centered around a capillary (arrow) (hematoxylin-eosin, 345X). (C) Brain tumor from a mouse 
(FO 413) killed at age 60 d (hematoxylin-eosin, 57X). The mass of poorly differentiated tumor cells is located adjacent to the habenular 
nuclei (asterisks). (Arrow) ependymal cells; (small black arrowhead) choroid plexus; (black squares) dentate gyri. The enlarged aqueduct 
(large black arrowhead) is due to the severe hydrocephalus caused by the growth of the tumor. (D) Midbrain tumor section from a mouse 
killed at age 45 d (family 417) showing the Homer-Wright rosette formation (arrow) (hematoxylin-eosin, 270X).
Scattered erythrocytes were usually observed in the lumens 
of the capillaries (Fig. 3 B). Characteristic Flexner-Winter- 
steiner rosettes, typically associated with retinoblastomas 
(34), could not be identified, but the less specific Homer 
Wright rosettes (34) were clearly observed in both the retinal 
and brain tumors (Figs. 3 D, and 4 A). Coronal sections of 
the brain tumors revealed poorly differentiated neoplasms 
with the histologic features usually encountered in primitive 
neuroectodermal tumors of infancy (Fig. 3 C). The cerebral 
tumors involved mostly the diencephalon, adjacent to the 
third ventricle, and surrounded the aqueduct and the habenu­
lar nuclei without involving the choroid plexus (Fig. 3 C). 
The tumors also extended to the midbrain and fourth ventri­
cle. The cerebral neoplasms were quite advanced at the time 
the animals were killed. Many tumor cells showed wide­
spread leptomeningeal infiltration along the Virchow-Robin 
spaces surrounding the blood vessels as they enter the brain. 
By electron microscopy, the tumor cells showed large pleo­
morphic nuclei with formation of nuclear blebs and numer­
ous polyribosomes, scattered mitochondria and dilated cis- 
temae of smooth-surfoced endoplasmic reticulum (Font et 
al., unpublished results). The exact origin of the tumor was 
not clearly discernible in the sections examined.
Although the retinal and brain tumors were highly un­
differentiated, the neoplastic cells reacted with antibodies to 
neuron-specific enolase, S antigen and Letf7. S-antigen (ar- 
restin) is not a photoreceptor specific protein and has been 
identified in the non-neoplastic state in pinealocytes, lens 
fiber, and epithelial cells, cerebellum and cerebral cortex 
(7), and also in several primitive neuroectodermal tumors of 
man (21). The tumor cells were not reactive with either anti­
bodies against neurofilament and GFAP, or with photorecep­
tor specific antibodies (see legend of Tkble II), but were reac­
tive with antibodies to T antigen (Fig. 4 B).
Discussion
Expression of SV40 T antigen in the retina of transgenic mice 
driven by the mouse opsin promoter leads to a rapidly 
progressing retinal degeneration associated with sustained 
DNA synthesis and mitotic cycles in the cells of the outer nu­
clear layer (2). To investigate whether the onset of expression 
of the oncogene or the cell specificity of the promoter is 
responsible for the resulting phenotype, another retina 
specific promoter was used to direct expression of T antigen 
to the photoreceptor cells of transgenic mice. The human






Table II. Immunohistochemical Characterization o f Retinal 
and Brain Tumors
Antibodies against
Mouse (F0) NSE Synapto. Leu 7 T antigen S antigen
666 OD (417) + + _ + / NP + /
666 OS (417) +  + + + / NP -
666 Br (417) + + + + / NP + +
1257 OD (417) - + NP NP NP
1257 Br (417) NP +  + -f~ "¥ NP + +
1258 OS (417) NP + 4* + / + / + /
1258 Br (417) NP + + / + f + / + /
726 OD (437) - + / + f NP -
726 OS (437) - - + / + /
726 Br (437) + - + / +  +
916 Br (437) + + + — — + +
Immunoreactivity of tumors to different antibodies were assessed by staining 
sections with the avidin-biotin immunoperoxidase method and using hematoxy­
lin as counter stain. The presence of brown precipitant was used to indicate im­
munoreactivity. All mice were adult when killed, but the developmental stage 
of the tumor differed depending on the individual mouse. The results shown 
were from an average of 15 sections from each antibody. Column mouse F„, 
founder mouse nomenclature (Br, brain; OS, left eye; OD, right eye. Numbers 
in parentheses refer to individual mouse families). NSE, neuron-specific eno- 
lase; Synapto.; synaptophysin; Leu 7, human natural killer cells specific anti­
gen. f, focal (few foci only); NP, not performed; + , weak; + +  , moderate; 
+ +  + , strong; negative. Immunohistochemical stains for glial fibrillary 
acidic protein (GFAP), neurofilament (NF), rhodopsin, and rod cGMP phos­
phodiesterase (PDE) were negative (not shown).
IRBP-promoter has previously been used to direct expres­
sion of the bacterial CAT gene to the retina and pineal gland 
of transgenic mice (24). Expression of the IRBP/CAT trans­
gene, irrespective of the site of integration, starts at em­
bryonic day 13 (Fig. 1), a time when developing retinal cells 
have just begun the initial differentiation into rod and cone 
photoreceptor cells (40). Utilizing a hybrid gene composed 
of the human IRBP promoter and the bacterial /3-galac- 
tosidase gene, Yokoyama et al. (40) detected expression in 
both rod and cone photoreceptor cells similar to the pattern 
of expression of the endogenous IRBP gene (31). We chose 
to test the tissue specificity of the human IRBP promoter by
following the CAT activity in the retina of mice homozygous 
for the rd mutation. The rod photoreceptor cells of these 
mice rapidly degenerate starting at P10, while nuclei of the 
cone photoreceptor cells survive for at least 6 mo (28). We 
allowed matings of IRBP/CAT transgenic mice to rd/rd mice 
and selected for mice that are homozygous for the rd allele 
and carry the IRBP/CAT transgene. Our results show that ex­
pression of the CAT gene was directed to the photoreceptor 
cell layer in the retinas of the transgenic animals.
Because hIRBP/CAT transgene expression was shown to 
start as early as El 3, this promoter was chosen to direct T 
antigen expression to the retina of transgenic mice. We found 
that expression of T antigen driven by the hIRBP promoter 
led to the formation of tumors in the brain and retina of mice. 
Tumors occurred at varying degrees of severity in different 
transgenic families, and this was most likely due to the effect 
of site of integration on the levels of expression of the trans­
gene. Animals exhibiting retinal tumors consistendy devel­
oped brain tumors, unlike the mouse model for retino­
blastoma reported earlier (39) where only 27% of the 
transgenic mice produced brain tumors whereas 100% of 
transgenic animals produced retinal tumors. This variation 
in the levels of tumor occurrence has been attributed to the 
effect of the site of integration of the transgene on the levels, 
cell type, or onset of expression (39). We also observed 
tumors in all founder mice that were homozygous for the rd 
mutation, suggesting that either tumors arose from surviving 
cone cells (22) or from photoreceptor cells before the onset 
of degeneration. We favor the latter possibility due to the 
early onset of expression of the transgene driven by the hu­
man IRBP promoter.
Normal retinal photoreceptor cells show varying degrees 
of reactivity to neuronal specific antibodies. Antibodies 
directed against neuron specific enolase, S antigen and Leu7 
show moderate to intense labeling of photoreceptor cells 
(11). However, photoreceptor cells show little or no reactiv­
ity with antibodies against neurofilaments, synaptophysin 
and GFAP. Therefore, it is not surprising that neuron specific 
enolase, S antigen and Leu7 were detected in the tumors. It
Figure 4. (A) Neuronal specific enolase staining o f  a retinal tumor (120X) for a 90-d old mouse (FO 437). Tumor, which is in close proximity 
to the lens (asterisk) shows the readily identifiable intact inner retinal layers (arrowhead). Also shown is the Homer-Wright rosette formation 
(arrow). (B ) Immunodetection o f T  antigen in the retinal tumor o f  a mouse (family 417) killed at age 60 d (305X). Ttomor cells in active 
mitosis (arrows) display positive staining for T antigen.






was also expected that the tumors would show absence of re­
activity with antibodies against GFAP and neurofilament be­
cause the tumors arose from the retinal outer layer. However, 
while normal photoreceptor cells did not react with anti- 
synaptophysin antibodies, the tumor cells reacted moder­
ately. This result combined with the negative staining of 
tumor cells with anti-opsin and anti-phosphodiesterase anti­
bodies (not shown) surest that either the tumors lost expres­
sion of some antigens and gained expression of others, due 
to the transformation by T antigen, or the early onset of ex­
pression of T antigen in the stem cells before the final differ­
entiation into rod and cone photoreceptors. Immunoreac- 
tivity to T antigen was restricted to mitotically active cells 
(Fig. 4 B), which may be caused by the accumulation of T 
antigen before the mitotic division.
The tumors observed in transgenic animals expressing 
HIT1 were of highly undifferentiated nature and therefore 
were designated primitive neuroectodermal tumors. The de­
velopment of retinal tumors in animals carrying HIT1, in 
contrast to the earlier observed retinal degeneration in 
animals carrying MOT1 (2) may have been due to expression 
of HIT1 in both the rod and cone photoreceptor cells. There­
fore, while rod photoreceptor cells degenerated, differentiat­
ing cone photoreceptor cells may have reacted differently to 
the expression of an oncogene resulting in the formation of 
tumors. This may explain the previous detection of cone- 
specific and the absence of rod photoreceptor-specific anti­
gens in retinoblastomas (5, 20). Alternatively, the earlier 
onset of expression of T antigen driven by the human IRBP 
promoter may be responsible for the formation of tumors.
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